DraftKings Incorporated (NASDAQ: DKNG), a prominent player in the online sports betting and fantasy sports industry, has experienced significant stock market activity recently.
Morningstar’s recent analysis suggests a "Buy" on Intellia Therapeutics, assigning a fair value of $85 per share, while the current trading price is significantly lower at $15.85.
American electric vehicle manufacturer Tesla Motors has urged its customers in Massachusetts to vote against the Northeastern state’s new “Right to Repair” initiative, which aims to add electric ve